Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results
|
Matinas BioPharma Holdings, Inc. (MTNB)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/30/2023 |
8-K
| Investor presentation |
05/12/2022 |
8-K
| Quarterly results |
09/13/2021 |
8-K
| Quarterly results |
02/01/2021 |
8-K
| Quarterly results |
01/14/2021 |
8-K
| Quarterly results |
06/02/2020 |
8-K
| Investor presentation |
08/13/2019 |
8-K
| Investor presentation, Quarterly results |
05/25/2018 |
8-K
| Investor presentation |
08/10/2017 |
8-K
| Investor presentation |
06/05/2017 |
8-K
| Form 8-K - Current report |
04/03/2017 |
8-K
| Form 8-K - Current report |
09/09/2015 |
8-K
| Investor presentation |
02/02/2015 |
8-K
| Investor presentation |
01/30/2015 |
8-K
| Investor presentation
Docs:
|
"Agreement and Plan of Merger, by and among Matinas BioPharma Holdings, Inc., Saffron Merger Sub, Inc., Aquarius Biotechnologies, Inc. and J. Carl Craft, as the stockholder representative",
"Matinas BioPharma Establishes Lipid-Based, Anti-Infective Platform, with Acquisition of Aquarius BioTechnologies Inc.",
"Forward Looking Statement This presentation contains "forward - looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including those relating to the Company’s product development, clinical and regulatory timelines, market opportunity, cash flow and other statements that are predictive in nature, that depend upon or refer to future events or conditions. All statements other than statements of historical fact are statements that could be forward - looking statements. Forward - looking statements include words such as “expects,” “anticipates,” “intends,” “plans,“ “could”, “believes,” “estimates” and similar expressions. These statements involve known and unknown risks, uncertainties and other factors which may cause actual results to be materially di..." |
|
08/08/2014 |
8-K
| Investor presentation |
04/30/2014 |
8-K
| Investor presentation |
|
|